{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:57:52Z","timestamp":1782741472540,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100031991","name":"Horus Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100031991","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40123-026-01416-y","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T05:12:52Z","timestamp":1781241172000},"page":"2431-2440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In Vitro Bactericidal Activity of Propamidine 0.1% and Other Ophthalmic Antiseptics on Conjunctivitis and Blepharitis Strains"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6285-253X","authenticated-orcid":false,"given":"Adrien","family":"Paschier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Chauchat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayette","family":"Rebika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Sahyoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"1416_CR1","unstructured":"European Committee for Standardization (CEN). Chemical antiseptics and disinfectants \u2014 quantitative suspension test for the evaluation of the basic bactericidal activity of chemical antiseptics and disinfectants \u2014 test method and requirements (phase 1). NF EN\u00a01040:2026. Brussels: CEN."},{"issue":"3","key":"1416_CR2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.18502\/jovr.v15i3.7456","volume":"15","author":"AA Azari","year":"2020","unstructured":"Azari AA, Arabi A. Conjunctivitis: a systematic review. J Ophthalmic Vis Res. 2020;15(3):372\u201395. https:\/\/doi.org\/10.18502\/jovr.v15i3.7456.","journal-title":"J Ophthalmic Vis Res"},{"issue":"1","key":"1416_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-9-13","volume":"9","author":"AF Smith","year":"2009","unstructured":"Smith AF, Waycaster C. Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States. BMC Ophthalmol. 2009;9(1):13. https:\/\/doi.org\/10.1186\/1471-2415-9-13.","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"1416_CR4","doi-asserted-by":"publisher","first-page":"P50","DOI":"10.1016\/j.ophtha.2023.12.036","volume":"131","author":"A Lin","year":"2024","unstructured":"Lin A, Ahmad S, Amescua G, et al. Blepharitis preferred practice pattern\u00ae. Ophthalmology. 2024;131(4):P50-86. https:\/\/doi.org\/10.1016\/j.ophtha.2023.12.036.","journal-title":"Ophthalmology"},{"issue":"7418","key":"1416_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7418.789","volume":"327","author":"RP Rietveld","year":"2003","unstructured":"Rietveld RP, Van Weert HCPM, Ter Riet G, Bindels PJE. Diagnostic impact of signs and symptoms in acute infectious conjunctivitis: systematic literature search. BMJ. 2003;327(7418):789.1. https:\/\/doi.org\/10.1136\/bmj.327.7418.789.","journal-title":"BMJ"},{"issue":"7459","key":"1416_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/bmj.38128.631319.AE","volume":"329","author":"RP Rietveld","year":"2004","unstructured":"Rietveld RP, Riet GT, Bindels PJE, Sloos JH, Van Weert HCPM. Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combinations of signs and symptoms. BMJ. 2004;329(7459):206\u201310. https:\/\/doi.org\/10.1136\/bmj.38128.631319.AE.","journal-title":"BMJ"},{"issue":"8","key":"1416_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2165\/11589020-000000000-00000","volume":"31","author":"J Benitez-del-Castillo","year":"2011","unstructured":"Benitez-del-Castillo J, Verboven Y, Stroman D, Kodjikian L. The role of topical Moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis: Clin Drug Investig. 2011;31(8):543\u201357. https:\/\/doi.org\/10.2165\/11589020-000000000-00000.","journal-title":"Clin Drug Investig"},{"issue":"4","key":"1416_CR8","doi-asserted-by":"publisher","first-page":"P134","DOI":"10.1016\/j.ophtha.2023.12.037","volume":"131","author":"AY Cheung","year":"2024","unstructured":"Cheung AY, Choi DS, Ahmad S, et al. Conjunctivitis preferred practice pattern. Ophthalmology. 2024;131(4):P134-204. https:\/\/doi.org\/10.1016\/j.ophtha.2023.12.037.","journal-title":"Ophthalmology"},{"issue":"8","key":"1416_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jfo.2015.01.012","volume":"38","author":"I Bezza Benkaouha","year":"2015","unstructured":"Bezza Benkaouha I, Le Brun C, Pisella PJ, Chandenier J, Lanotte P. La flore bact\u00e9rienne dans les bl\u00e9pharites. J Fr Ophtalmol. 2015;38(8):723\u20138. https:\/\/doi.org\/10.1016\/j.jfo.2015.01.012.","journal-title":"J Fr Ophtalmol"},{"key":"1416_CR10","doi-asserted-by":"publisher","DOI":"10.4137\/OED.S4866","volume":"3","author":"D Bremond-Gignac","year":"2011","unstructured":"Bremond-Gignac D, Chiambaretta F, Milazzo S. A European perspective on topical ophthalmic antibiotics: current and evolving options. Ophthalmol Eye Dis. 2011;3:OED.S4866. https:\/\/doi.org\/10.4137\/OED.S4866.","journal-title":"Ophthalmol Eye Dis"},{"issue":"590","key":"1416_CR11","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.3399\/bjgp11X593811","volume":"61","author":"J Jefferis","year":"2011","unstructured":"Jefferis J, Perera R, Everitt H, et al. Acute infective conjunctivitis in primary care: who needs antibiotics? An individual patient data meta-analysis. Br J Gen Pract. 2011;61(590):e542\u20138. https:\/\/doi.org\/10.3399\/bjgp11X593811.","journal-title":"Br J Gen Pract"},{"issue":"521","key":"1416_CR12","first-page":"962","volume":"55","author":"A Sheikh","year":"2005","unstructured":"Sheikh A, Hurwitz B. Topical antibiotics for acute bacterial conjunctivitis: Cochrane systematic review and meta-analysis update. Br J Gen Pract J R Coll Gen Pract. 2005;55(521):962\u20134.","journal-title":"Br J Gen Pract J R Coll Gen Pract."},{"issue":"16","key":"1416_CR13","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1001\/jama.2013.280318","volume":"310","author":"AA Azari","year":"2013","unstructured":"Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA. 2013;310(16):1721. https:\/\/doi.org\/10.1001\/jama.2013.280318.","journal-title":"JAMA"},{"issue":"5","key":"1416_CR14","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ophtha.2012.11.005","volume":"120","author":"SB Dave","year":"2013","unstructured":"Dave SB, Toma HS, Kim SJ. Changes in ocular flora in eyes exposed to ophthalmic antibiotics. Ophthalmology. 2013;120(5):937\u201341. https:\/\/doi.org\/10.1016\/j.ophtha.2012.11.005.","journal-title":"Ophthalmology"},{"issue":"8","key":"1416_CR15","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.ophtha.2017.04.034","volume":"124","author":"NS Shekhawat","year":"2017","unstructured":"Shekhawat NS, Shtein RM, Blachley TS, Stein JD. Antibiotic prescription fills for acute conjunctivitis among enrollees in a large United States managed care network. Ophthalmology. 2017;124(8):1099\u2013107. https:\/\/doi.org\/10.1016\/j.ophtha.2017.04.034.","journal-title":"Ophthalmology"},{"issue":"7","key":"1416_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8071033","volume":"8","author":"F Petrillo","year":"2020","unstructured":"Petrillo F, Pignataro D, Lavano MA, et al. Current evidence on the ocular surface microbiota and related diseases. Microorganisms. 2020;8(7):1033. https:\/\/doi.org\/10.3390\/microorganisms8071033.","journal-title":"Microorganisms"},{"key":"1416_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108269","volume":"201","author":"R Mencucci","year":"2020","unstructured":"Mencucci R, Favuzza E, Bottino P, et al. A new ophthalmic formulation containing antiseptics and dexpanthenol: in vitro antimicrobial activity and effects on corneal and conjunctival epithelial cells. Exp Eye Res. 2020;201:108269. https:\/\/doi.org\/10.1016\/j.exer.2020.108269.","journal-title":"Exp Eye Res"},{"issue":"6","key":"1416_CR18","doi-asserted-by":"publisher","first-page":"350.e1","DOI":"10.1016\/j.jaapos.2021.06.006","volume":"25","author":"HM Frost","year":"2021","unstructured":"Frost HM, Sebastian T, Durfee J, Jenkins TC. Ophthalmic antibiotic use for acute infectious conjunctivitis in children. J Am Assoc Pediatr Ophthalmol Strabismus. 2021;25(6):350.e1-350.e7. https:\/\/doi.org\/10.1016\/j.jaapos.2021.06.006.","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"1416_CR19","doi-asserted-by":"publisher","unstructured":"Collyres et autres topiques antibiotiques dans les infections oculaires superficielles. Recommandations. M\u00e9decine Mal Infect. 2004;34(12):608\u201311. https:\/\/doi.org\/10.1016\/j.medmal.2004.10.009.","DOI":"10.1016\/j.medmal.2004.10.009"},{"key":"1416_CR20","unstructured":"Charles-Weber S, Mazet R, Chiquet C, Chast F. Antiseptics. In: M\u00e9dicaments et bioth\u00e9rapie en ophtalmologie. Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Opthalmologie. https:\/\/www.sfo-online.fr\/sites\/www.sfo-online.fr\/files\/medias\/documents\/Rapport-SFO-Medicaments-Biotherapies-ophtalmologie.pdf. Accessed 20 Nov 2025"},{"issue":"1","key":"1416_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1128\/CMR.12.1.147","volume":"12","author":"G McDonnell","year":"1999","unstructured":"McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12(1):147\u201379. https:\/\/doi.org\/10.1128\/CMR.12.1.147.","journal-title":"Clin Microbiol Rev"},{"key":"1416_CR22","unstructured":"Brolene 0.1% w\/v Eye Drops Solution. Summary of Product Characteristics. Updated 18 January 2022. https:\/\/www.medicines.org.uk\/emc\/product\/13181\/smpc\/print. Accessed 17 Nov 2025"},{"key":"1416_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120924","volume":"607","author":"M Mofidfar","year":"2021","unstructured":"Mofidfar M, Abdi B, Ahadian S, et al. Drug delivery to the anterior segment of the eye: a review of current and future treatment strategies. Int J Pharm. 2021;607:120924. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120924.","journal-title":"Int J Pharm"},{"key":"1416_CR24","first-page":"9","volume":"315","author":"I Vaninbroukx","year":"2010","unstructured":"Vaninbroukx I, Van Calster J, Van Calster B, Spileers W, Verhaegen J, Stalmans P. Preoperative eye disinfection in vitrectomy surgery using antibiotic or antiseptic eyedrops. Bull Soc Belge Ophtalmol. 2010;315:9\u201312.","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"1416_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/aos.15732","author":"M Ferrara","year":"2024","unstructured":"Ferrara M, Gatti F, Lockington D, et al. Antimicrobials and antiseptics: lowering effect on ocular surface bacterial flora\u2014a systematic review. Acta Ophthalmol (Copenh). 2024. https:\/\/doi.org\/10.1111\/aos.15732.","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"4","key":"1416_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.26355\/eurrev_202504_37163","volume":"29","author":"C Cagini","year":"2025","unstructured":"Cagini C, Spinosi M, Della Lena F, et al. Antiseptic activity of different ophthalmic formulations: an in vitro study. Eur Rev Med Pharmacol Sci avr. 2025;29(4):160\u201373. https:\/\/doi.org\/10.26355\/eurrev_202504_37163.","journal-title":"Eur Rev Med Pharmacol Sci avr"},{"key":"1416_CR27","unstructured":"Bodaghi B, Bourcier T, Labetoulle M. Rapport SFO Infections en ophtalmologie [Internet]. Disponible sur: https:\/\/www.sfo-online.fr\/files\/rapports-sfo\/2024\/sforender\/index.html."},{"issue":"11","key":"1416_CR28","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s40123-025-01250-8","volume":"14","author":"A Grzybowski","year":"2025","unstructured":"Grzybowski A, Bajori\u016bnait\u0117 A, \u017demaitien\u0117 R. The rising importance of antiseptics in ophthalmology: from endophthalmitis prevention to treatment of ocular infections. Ophthalmol Ther. 2025;14(11):2735\u201352. https:\/\/doi.org\/10.1007\/s40123-025-01250-8.","journal-title":"Ophthalmol Ther"},{"key":"1416_CR29","doi-asserted-by":"publisher","DOI":"10.22608\/APO.2017343","author":"A Grzybowski","year":"2019","unstructured":"Grzybowski A. More antisepsis, less antibiotics whenever possible. Asia-Pac J Ophthalmol. 2019. https:\/\/doi.org\/10.22608\/APO.2017343.","journal-title":"Asia-Pac J Ophthalmol"},{"key":"1416_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001211.pub4","author":"YY Chen","year":"2023","unstructured":"Chen YY, Liu ASH, Nurmatov U, Van Schayck OC, Kuo IC. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Eyes and Vision Group, \u00e9diteur. Cochrane Database Syst Rev. 2023. https:\/\/doi.org\/10.1002\/14651858.CD001211.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1416_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.pop.2015.05.001","volume":"42","author":"SA Alfonso","year":"2015","unstructured":"Alfonso SA, Fawley JD, Alexa LuX. Conjunctivitis. Prim Care. 2015;42(3):325\u201345. https:\/\/doi.org\/10.1016\/j.pop.2015.05.001.","journal-title":"Prim Care"},{"issue":"8","key":"1416_CR32","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jfo.2014.05.004","volume":"37","author":"N Bouheraoua","year":"2014","unstructured":"Bouheraoua N, Labb\u00e9 A, Chaumeil C, Liang Q, Laroche L, Borderie V. K\u00e9ratites amibiennes. J Fr Ophtalmol. 2014;37(8):640\u201352. https:\/\/doi.org\/10.1016\/j.jfo.2014.05.004.","journal-title":"J Fr Ophtalmol"},{"issue":"2","key":"1416_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.survophthal.2016.10.009","volume":"62","author":"LC Carrijo-Carvalho","year":"2017","unstructured":"Carrijo-Carvalho LC, Sant\u2019ana VP, Foronda AS, De Freitas D, De Souza Carvalho FR. Therapeutic agents and biocides for ocular infections by free-living amoebae of Acanthamoeba genus. Surv Ophthalmol. 2017;62(2):203\u201318. https:\/\/doi.org\/10.1016\/j.survophthal.2016.10.009.","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"1416_CR34","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/jamaophthalmol.2024.2211","volume":"142","author":"DJ Shapiro","year":"2024","unstructured":"Shapiro DJ, Geanacopoulos AT, Subramanian SV, Wu AC, Bardach NS, Oke I. Antibiotic treatment and health care use in children and adolescents with conjunctivitis. JAMA Ophthalmol. 2024;142(8):779. https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.2211.","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"1416_CR35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1186\/s13104-020-05389-4","volume":"13","author":"A Farajzadeh Sheikh","year":"2020","unstructured":"Farajzadeh Sheikh A, Feghhi M, Torabipour M, Saki M, Veisi H. Low prevalence of Moraxella catarrhalis in the patients who suffered from conjunctivitis in the southwest of Iran. BMC Res Notes d\u00e9c. 2020;13(1):547. https:\/\/doi.org\/10.1186\/s13104-020-05389-4.","journal-title":"BMC Res Notes d\u00e9c"},{"issue":"11","key":"1416_CR36","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1097\/ICO.0000000000002375","volume":"39","author":"A Pinna","year":"2020","unstructured":"Pinna A, Donadu MG, Usai D, Dore S, Boscia F, Zanetti S. In vitro antimicrobial activity of a new ophthalmic solution containing hexamidine diisethionate 0.05% (Keratosept). Cornea. 2020;39(11):1415\u20138. https:\/\/doi.org\/10.1097\/ICO.0000000000002375.","journal-title":"Cornea"},{"issue":"3","key":"1416_CR37","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/ICO.0b013e31815c5a3f","volume":"27","author":"A Pinna","year":"2008","unstructured":"Pinna A, Usai D, Sechi LA, Molicotti P, Zanetti S, Carta A. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers. Cornea avr. 2008;27(3):320\u20136. https:\/\/doi.org\/10.1097\/ICO.0b013e31815c5a3f.","journal-title":"Cornea avr"},{"issue":"11","key":"1416_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11274-021-03149-5","volume":"37","author":"Y Ikken","year":"2021","unstructured":"Ikken Y, Charof R, Elouennass M, Sekhsokh Y. The novel biphasic medium for transport, culture and conservation at an ambient temperature of Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae. World J Microbiol Biotechnol. 2021;37(11):187. https:\/\/doi.org\/10.1007\/s11274-021-03149-5.","journal-title":"World J Microbiol Biotechnol"},{"issue":"5","key":"1416_CR39","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1469-0691.2009.02837.x","volume":"16","author":"M Grare","year":"2010","unstructured":"Grare M, Dibama HM, Lafosse S, et al. Cationic compounds with activity against multidrug-resistant bacteria: interest of a new compound compared with two older antiseptics, hexamidine and chlorhexidine. Clin Microbiol Infect mai. 2010;16(5):432\u20138. https:\/\/doi.org\/10.1111\/j.1469-0691.2009.02837.x.","journal-title":"Clin Microbiol Infect mai"},{"issue":"1","key":"1416_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.18240\/ijo.2020.01.13","volume":"13","author":"MV Budzinskaya","year":"2020","unstructured":"Budzinskaya MV. Ocular flora in patients undergoing intravitreal injections: antibiotic resistance patterns and susceptibility to antiseptic picloxydine. Int J Ophthalmol. 2020;13(1):85\u201392. https:\/\/doi.org\/10.18240\/ijo.2020.01.13.","journal-title":"Int J Ophthalmol"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01416-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01416-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01416-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:26:15Z","timestamp":1782739575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01416-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1416"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01416-y","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors (Adrien Paschier, Laure Chauchat, Hayette Rebika, Marwan Sahyoun, Camille Guerin) were employed by Horus Pharma at the time of the article publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}},{"value":"This study does not involve any new experiments with human participants or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}